<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2022-1-89-95</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-4702</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Влияние системного применения мелатонина на интенсивность свободно-радикальной деструкции липидов и белков ожоговой раны в динамике экспериментальной термической травмы</article-title><trans-title-group xml:lang="en"><trans-title>The effect of systemic melatonin administration on the intensity of free radical damage to lipids and proteins in the burn wound in the dynamics of experimental thermal injury</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6487-9083</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осиков</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Osikov</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Осиков Михаил Владимирович – д-р мед. наук, профессор, зав. кафедрой патологической физиологии</p><p>454092, г. Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>64, Vorovskogo Str., Chelyabinsk, 454092</p></bio><email xlink:type="simple">prof.osikov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3061-7621</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агеева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ageeva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Агеева Анна Алексеевна – ассистент, кафедра патологической физиологии</p><p>454092, г. Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>64, Vorovskogo Str., Chelyabinsk, 454092</p></bio><email xlink:type="simple">anne.ageeva.r@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9700-3886</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агеев</surname><given-names>Ю. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ageev</surname><given-names>Yu. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Агеев Юрий Иванович – канд. мед. наук, ст. преподаватель, кафедра патологической физиологии</p><p>454092, г. Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>64, Vorovskogo Str., Chelyabinsk, 454092</p></bio><email xlink:type="simple">doctorageev@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5687-3976</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синицкий</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitsky</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Синицкий Антон Иванович – д-р мед. наук, доцент, зав. кафедрой биохимии им. Р.И. Лифшица</p><p>454092, г. Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>64, Vorovskogo Str., Chelyabinsk, 454092</p></bio><email xlink:type="simple">sinitskiyai@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8865-6412</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шатрова</surname><given-names>Ю. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Shatrova</surname><given-names>Yu. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шатрова Юлия Михайловна – канд. биол. наук, ст. преподаватель, кафедра биохимии им. Р.И. Лифшица</p><p>454092, г. Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>64, Vorovskogo Str., Chelyabinsk, 454092</p></bio><email xlink:type="simple">shatr20@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Южно-Уральский государственный медицинский университет (ЮУГМУ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>South Ural State Medical University (SUSMU)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>14</day><month>04</month><year>2022</year></pub-date><volume>21</volume><issue>1</issue><fpage>89</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Осиков М.В., Агеева А.А., Агеев Ю.И., Синицкий А.И., Шатрова Ю.М., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Осиков М.В., Агеева А.А., Агеев Ю.И., Синицкий А.И., Шатрова Ю.М.</copyright-holder><copyright-holder xml:lang="en">Osikov M.V., Ageeva A.A., Ageev Y.I., Sinitsky A.I., Shatrova Y.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/4702">https://bulletin.ssmu.ru/jour/article/view/4702</self-uri><abstract><p>Цель работы – исследовать влияние мелатонина (МТ) на содержание продуктов перекисного окисления липидов (ПОЛ) и окислительной модификации белков (ОМБ) в гомогенате ожоговой раны при экспериментальной термической травме (ТТ).</p><sec><title>Материалы и методы</title><p>Материалы и методы. На самцах крыс линии Wistar моделировали ТТ степени IIIА площадью 3,5% контактом кожи с кипящей водой в течение 12 с. МТ применяли внутрибрюшинно (10 мг/кг), 1 раз/сут в течение 5 сут. В гомогенате ожоговой раны на 5, 10 и 20-е сут определяли содержание продуктов ПОЛ в гептановой и изопропанольной фазах липидного экстракта, продуктов ОМБ.</p></sec><sec><title>Результаты</title><p>Результаты. В ожоговой ране увеличивалось содержание вторичных и конечных продуктов ПОЛ в гептановой фазе, конечных продуктов в изопропанольной фазе липидного экстракта; увеличивалось содержание первичных и вторичных продуктов ОМБ нейтрального характера на 5, 10 и 20-е сут, вторичных продуктов нейтрального характера – на 10-е и 20-е сут. Применение МТ снижает содержание конечных продуктов ПОЛ в гептановой фазе, вторичных и конечных продуктов ПОЛ в изопропанольной фазе липидного экстракта; суммарное количество продуктов ОМБ за счет первичных и вторичных продуктов нейтрального характера.</p></sec><sec><title>Заключение</title><p>Заключение. В динамике 20-суточного наблюдения при ТТ кожи в ожоговой ране накапливаются продукты ПОЛ и ОМБ, применение МТ в суммарной дозе 50 мг/кг приводит к снижению и частичному восстановлению содержания продуктов ПОЛ и ОМБ, что может ограничивать вторичную альтерацию, ускорять заживление ожоговой раны.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To assess the effect of melatonin (MT) on the content of lipid peroxidation (LPO) and protein oxidation (PO) products in the tissue homogenate from the burn wound in experimental thermal injury (TI).</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Third-degree (IIIA) TI with a relative area of 3.5% was modeled on male Wistar rats via contact of the skin with boiling water. Intraperitoneal administration of MT (10 mg / kg) was performed once a day for 5 days. On days 5, 10, and 20, LPO products in the heptane and isopropanol phases of lipid extraction and PO products were determined in the tissue homogenate from the burn wound.</p></sec><sec><title>Results</title><p>Results. The content of secondary and end products of LPO in the heptane phase and end products in the isopropanol phase increased in the wound. The content of primary and secondary PO products of neutral nature increased on days 5, 10, and 20, and the level of secondary PO products of neutral nature elevated on days 10 and 20. Administration of MT reduced the content of LPO end products in the heptane phase, secondary and end products of LPO in the isopropanol phase, and the total amount of PO products due to primary and secondary products of neutral nature.</p></sec><sec><title>Conclusion</title><p>Conclusion. In the 20-day follow-up, LPO and PO products accumulated in the burn wound. The administration of MT at a total dose of 50 mg / kg led to reduction and partial restoration of the content of LPO and POM products, which can limit secondary alterations and accelerate healing of the burn wound.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мелатонин</kwd><kwd>термическая травма</kwd><kwd>перекисное окисление липидов</kwd><kwd>окислительная модификация белков</kwd></kwd-group><kwd-group xml:lang="en"><kwd>melatonin</kwd><kwd>thermal injury</kwd><kwd>lipid peroxidation</kwd><kwd>protein oxidative modification</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено при финансовой поддержке ФГБУ «Фонд содействия развитию малых форм предприятий в научно-технической сфере» по программе «У.М.Н.И.К.» (договор № 15583ГУ/2020 от 05.07.2020), РФФИ и Челябинской области (проект № 20-415-740016).</funding-statement><funding-statement xml:lang="en">The study was supported by the Foundation for Assistance to Small Innovative Enterprises in Science and Technology within the UMNIK program (agreement No. 15583GU/2020 of 05.07.2020), RFBR, and the Chelyabinsk region (Project No. 20-415-740016).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Осиков М.В. Роль орозомукоида в регуляции активности систем плазменного протеолиза при экспериментальной почечной недостаточности. Бюллетень экспериментальной биологии и медицины. 2009;48(7):27–30.</mixed-citation><mixed-citation xml:lang="en">Осиков М.В. Роль орозомукоида в регуляции активности систем плазменного протеолиза при экспериментальной почечной недостаточности. Бюллетень экспериментальной биологии и медицины. 2009;48(7):27–30.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Осиков М.В. Влияние эритропоэтина на процессы свободно-радикального окисления и экспрессию гликопротеинов в тромбоцитах при хронической почечной недостаточности. Бюллетень экспериментальной биологии и медицины. 2014;157(1):30–33.</mixed-citation><mixed-citation xml:lang="en">Осиков М.В. Влияние эритропоэтина на процессы свободно-радикального окисления и экспрессию гликопротеинов в тромбоцитах при хронической почечной недостаточности. Бюллетень экспериментальной биологии и медицины. 2014;157(1):30–33.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Осиков М.В., Телешева Л.Ф., Агеев Ю.И. Влияние эритропоэтина на апоптоз лимфоцитов при экспериментальной хронической почечной недостаточности. Бюллетень экспериментальной биологии и медицины. 2015;159(3):326–329.</mixed-citation><mixed-citation xml:lang="en">Осиков М.В., Телешева Л.Ф., Агеев Ю.И. Влияние эритропоэтина на апоптоз лимфоцитов при экспериментальной хронической почечной недостаточности. Бюллетень экспериментальной биологии и медицины. 2015;159(3):326–329.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Osikov M.V., Telesheva L.F., Ageev Y.I. Antioxidant effect of erythropoietin during experimental chronic renal failure. Bulletin of Experimental Biology and Medicine. 2015;160(2): 202–204. DOI: 10.1007/s10517-015-3128-x.</mixed-citation><mixed-citation xml:lang="en">Osikov M.V., Telesheva L.F., Ageev Y.I. Antioxidant effect of erythropoietin during experimental chronic renal failure. Bulletin of Experimental Biology and Medicine. 2015;160(2): 202–204. DOI: 10.1007/s10517-015-3128-x.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gus E.I., Shahrokhi S., Jeschke M.G. Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned. Burns. 2020;46(1):19–32. DOI: 10.1016/j.burns.2018.03.009.</mixed-citation><mixed-citation xml:lang="en">Gus E.I., Shahrokhi S., Jeschke M.G. Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned. Burns. 2020;46(1):19–32. DOI: 10.1016/j.burns.2018.03.009.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mitran M.I., Nicolae I., Tampa M., Mitran C.I., Caruntu C., Sarbu M.I. et al. Reactive сarbonyl species as potential pro-oxidant factors involved in lichen planus pathogenesis. Metabolites. 2019;9(10):E213. DOI: 10.3390/metabo9100213.</mixed-citation><mixed-citation xml:lang="en">Mitran M.I., Nicolae I., Tampa M., Mitran C.I., Caruntu C., Sarbu M.I. et al. Reactive сarbonyl species as potential pro-oxidant factors involved in lichen planus pathogenesis. Metabolites. 2019;9(10):E213. DOI: 10.3390/metabo9100213.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Qin F.J., Hu X.H., Chen Z., Chen X., Shen Y.M. Protective effects of tiopronin against oxidative stress in severely burned patients. Drug Des. Devel. Ther. 2019;13:2827–2832. DOI: 10.2147/dddt.s215927.</mixed-citation><mixed-citation xml:lang="en">Qin F.J., Hu X.H., Chen Z., Chen X., Shen Y.M. Protective effects of tiopronin against oxidative stress in severely burned patients. Drug Des. Devel. Ther. 2019;13:2827–2832. DOI: 10.2147/dddt.s215927.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">AbuBakr H.O., Aljuaydi S.H., Abou-Zeid S.M., El-Bahrawy A. Burn-induced multiple organ injury and protective effect of lutein in rats. Inflammation. 2018;41(3):760–772. DOI: 10.1007/s10753-018-0730-x.</mixed-citation><mixed-citation xml:lang="en">AbuBakr H.O., Aljuaydi S.H., Abou-Zeid S.M., El-Bahrawy A. Burn-induced multiple organ injury and protective effect of lutein in rats. Inflammation. 2018;41(3):760–772. DOI: 10.1007/s10753-018-0730-x.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hawkins C.L., Davies M.J. Detection, identification, and quantification of oxidative protein modifications. J. Biol. Chem. 2019;294(51):19683–19708. DOI: 10.1074/jbc.rev119.006217.</mixed-citation><mixed-citation xml:lang="en">Hawkins C.L., Davies M.J. Detection, identification, and quantification of oxidative protein modifications. J. Biol. Chem. 2019;294(51):19683–19708. DOI: 10.1074/jbc.rev119.006217.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gürünlüoğlu K., Demircan M., Taşçı A., Üremiş M.M., Türköz Y., Bağ H.G. et al. The effects of two different burn dressings on serum oxidative stress indicators in children with partial burn. J. Burn. Care Res. 2019;40(4):444–450. DOI: 10.1093/jbcr/irz037.</mixed-citation><mixed-citation xml:lang="en">Gürünlüoğlu K., Demircan M., Taşçı A., Üremiş M.M., Türköz Y., Bağ H.G. et al. The effects of two different burn dressings on serum oxidative stress indicators in children with partial burn. J. Burn. Care Res. 2019;40(4):444–450. DOI: 10.1093/jbcr/irz037.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y.Yu., Shen Y., Liu Q., Zhao Z., Sharma R., Reiter R.J. Melatonin synthesis and function: evolutionary history in animals and plants. Front. Endocrinol. (Lausanne). 2019;10:249. DOI: 10.3389/fendo.2019.00249.</mixed-citation><mixed-citation xml:lang="en">Zhao Y.Yu., Shen Y., Liu Q., Zhao Z., Sharma R., Reiter R.J. Melatonin synthesis and function: evolutionary history in animals and plants. Front. Endocrinol. (Lausanne). 2019;10:249. DOI: 10.3389/fendo.2019.00249.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Slominski A.T., Semak I., Fischer T.W., Kim T.K., Kleszczyński K., Hardeland R. et al. Metabolism of melatonin in the skin: Why is it important? Exp. Dermatol. 2017;26(7):563–568. DOI: 10.1111/exd.13208.</mixed-citation><mixed-citation xml:lang="en">Slominski A.T., Semak I., Fischer T.W., Kim T.K., Kleszczyński K., Hardeland R. et al. Metabolism of melatonin in the skin: Why is it important? Exp. Dermatol. 2017;26(7):563–568. DOI: 10.1111/exd.13208.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Janjetovic Z., Jarrett S.G., Lee E.F., Duprey C., Reiter R.J., Slominski A.T. Melatonin and its metabolites protect human melanocytes against UVB-induced damage: Involvement of NRF2-mediated pathways. Sci. Rep. 2017;7(1):1274. DOI: 10.1038/s41598-017-01305-2.</mixed-citation><mixed-citation xml:lang="en">Janjetovic Z., Jarrett S.G., Lee E.F., Duprey C., Reiter R.J., Slominski A.T. Melatonin and its metabolites protect human melanocytes against UVB-induced damage: Involvement of NRF2-mediated pathways. Sci. Rep. 2017;7(1):1274. DOI: 10.1038/s41598-017-01305-2.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rusanova I., Martínez-Ruiz L., Florido J., Rodríguez-Santana C., Guerra-Librero A., Acuña-Castroviejo D. et al. Protective effects of melatonin on the skin: future perspectives. Int. J. Mol. Sci. 2019;20(19):4948. DOI: 10.3390/ijms20194948.</mixed-citation><mixed-citation xml:lang="en">Rusanova I., Martínez-Ruiz L., Florido J., Rodríguez-Santana C., Guerra-Librero A., Acuña-Castroviejo D. et al. Protective effects of melatonin on the skin: future perspectives. Int. J. Mol. Sci. 2019;20(19):4948. DOI: 10.3390/ijms20194948.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tordjman S., Chokron S., Delorme R., Charrier A., Bellissant É., Jaafari N. et al. Melatonin: pharmacology, functions and therapeutic benefits. Curr. Neuropharmacol. 2017;15(3):434–443. DOI: 10.2174/1570159x14666161228122115.</mixed-citation><mixed-citation xml:lang="en">Tordjman S., Chokron S., Delorme R., Charrier A., Bellissant É., Jaafari N. et al. Melatonin: pharmacology, functions and therapeutic benefits. Curr. Neuropharmacol. 2017;15(3):434–443. DOI: 10.2174/1570159x14666161228122115.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Львовская Е.И., Волчегорский И.А., Шемяков С.Е., Лифшиц Р.И. Спектрофотометрическое определение конечных продуктов. Вопросы медицинской химии. 1991;37(4):92–93.</mixed-citation><mixed-citation xml:lang="en">Львовская Е.И., Волчегорский И.А., Шемяков С.Е., Лифшиц Р.И. Спектрофотометрическое определение конечных продуктов. Вопросы медицинской химии. 1991;37(4):92–93.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Фомина М.А., Абаленихина Ю.В. Способ комплексной оценки содержания продуктов окислительной модификации белков в тканях и биологических жидкостях: методические рекомендации. Рязань: РИО РязГМУ, 2014:60.</mixed-citation><mixed-citation xml:lang="en">Фомина М.А., Абаленихина Ю.В. Способ комплексной оценки содержания продуктов окислительной модификации белков в тканях и биологических жидкостях: методические рекомендации. Рязань: РИО РязГМУ, 2014:60.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Olczyk P., Komosinska-Vassev K., Ramos P., Mencner Ł., Olczyk K., Pilawa B. Application of numerical analysis of the shape of electron paramagnetic resonance spectra for determination of the number of different groups of radicals in the burn wounds. Oxid. Med. Cell Longev. 2017;2017:4683102. DOI: 10.1155/2017/4683102.</mixed-citation><mixed-citation xml:lang="en">Olczyk P., Komosinska-Vassev K., Ramos P., Mencner Ł., Olczyk K., Pilawa B. Application of numerical analysis of the shape of electron paramagnetic resonance spectra for determination of the number of different groups of radicals in the burn wounds. Oxid. Med. Cell Longev. 2017;2017:4683102. DOI: 10.1155/2017/4683102.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nakazawa H., Ikeda K., Shinozaki S., Yasuhara S., Yu Y.M., Martyn J.A.J. et al. Coenzyme Q10 protects against burn-induced mitochondrial dysfunction and impaired insulin signaling in mouse skeletal muscle. FEBS Open Bio. 2019;9(2):348–363. DOI: 10.1002/2211-5463.12580.</mixed-citation><mixed-citation xml:lang="en">Nakazawa H., Ikeda K., Shinozaki S., Yasuhara S., Yu Y.M., Martyn J.A.J. et al. Coenzyme Q10 protects against burn-induced mitochondrial dysfunction and impaired insulin signaling in mouse skeletal muscle. FEBS Open Bio. 2019;9(2):348–363. DOI: 10.1002/2211-5463.12580.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lee Y.H., Bang E.S., Lee J.H., Lee J.D., Kang D.R., Hong J. et al. Serum concentrations of trace elements zinc, copper, selenium, and manganese in critically Ill patients. Biol. Trace Elem. Res. 2019;188(2):316–325. DOI: 10.1007/s12011-018-1429-4.</mixed-citation><mixed-citation xml:lang="en">Lee Y.H., Bang E.S., Lee J.H., Lee J.D., Kang D.R., Hong J. et al. Serum concentrations of trace elements zinc, copper, selenium, and manganese in critically Ill patients. Biol. Trace Elem. Res. 2019;188(2):316–325. DOI: 10.1007/s12011-018-1429-4.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Samuel T.J., Nelson M.D., Nasirian A., Jaffery M., Moralez G., Romero S.A. et al. Cardiac structure and function in well-healed burn survivors. J. Burn. Care Res. 2019;40(2):235–241. DOI: 10.1093/jbcr/irz008.</mixed-citation><mixed-citation xml:lang="en">Samuel T.J., Nelson M.D., Nasirian A., Jaffery M., Moralez G., Romero S.A. et al. Cardiac structure and function in well-healed burn survivors. J. Burn. Care Res. 2019;40(2):235–241. DOI: 10.1093/jbcr/irz008.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Valacchi G., Virgili F., Cervellati C. et al. OxInflammation: from subclinicalcCondition to pathological biomarker. Front. Physiol. 2018;9:858. DOI: 10.3389/fphys.2018.00858.</mixed-citation><mixed-citation xml:lang="en">Valacchi G., Virgili F., Cervellati C. et al. OxInflammation: from subclinicalcCondition to pathological biomarker. Front. Physiol. 2018;9:858. DOI: 10.3389/fphys.2018.00858.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J., Cho Y.S., Jung H., Choi I. Pharmacological regulation of oxidative stress in stem cells. Oxid. Med. Cell. Longev. 2018;2018:4081890. DOI: 10.1155/2018/4081890.</mixed-citation><mixed-citation xml:lang="en">Lee J., Cho Y.S., Jung H., Choi I. Pharmacological regulation of oxidative stress in stem cells. Oxid. Med. Cell. Longev. 2018;2018:4081890. DOI: 10.1155/2018/4081890.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Slominski A.T., Zmijewski M.A., Semak I., Kim T.K., Janjetovic Z., Slominski R.M. et al. Melatonin, mitochondria, and the skin. Cell Mol. Life Sci. 2017;74(21):3913–3925. DOI: 10.1007/s00018-017-2617-7.</mixed-citation><mixed-citation xml:lang="en">Slominski A.T., Zmijewski M.A., Semak I., Kim T.K., Janjetovic Z., Slominski R.M. et al. Melatonin, mitochondria, and the skin. Cell Mol. Life Sci. 2017;74(21):3913–3925. DOI: 10.1007/s00018-017-2617-7.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Reiter R.J., Rosales-Corral S., Tan D.X., Jou M.J., Galano A., Xu B. Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas. Cell Mol. Life Sci. 2017;74(21):3863-3881. DOI: 10.1007/s00018-017-2609-7.</mixed-citation><mixed-citation xml:lang="en">Reiter R.J., Rosales-Corral S., Tan D.X., Jou M.J., Galano A., Xu B. Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas. Cell Mol. Life Sci. 2017;74(21):3863-3881. DOI: 10.1007/s00018-017-2609-7.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
